OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of endothelin and endothelin receptor antagonists in renal disease
Wolfgang Neuhofer, David Pittrow
European Journal of Clinical Investigation (2006) Vol. 36, Iss. s3, pp. 78-88
Closed Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545
Zaid Abassi, Shadi Hamoud, Ahmad Hassan, et al.
Oncotarget (2017) Vol. 8, Iss. 21, pp. 34191-34204
Open Access | Times Cited: 36

Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome
Florence Wong, Kevin Moore, Jasper Dingemanse, et al.
Hepatology (2007) Vol. 47, Iss. 1, pp. 160-168
Open Access | Times Cited: 46

Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats
Haoran Liu, Xiaoyun Tang, De‐Zai Dai, et al.
Journal of Ethnopharmacology (2008) Vol. 118, Iss. 3, pp. 466-472
Closed Access | Times Cited: 45

Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade*
Nishith Patel, Tibor Tóth, Ceri Jones, et al.
Critical Care Medicine (2011) Vol. 39, Iss. 4, pp. 793-802
Closed Access | Times Cited: 40

Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissue
Chen Hu, Cong Xia, De‐Zai Dai, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2011) Vol. 383, Iss. 3, pp. 309-319
Closed Access | Times Cited: 38

Reducing Oxygen Demand to Alleviate Acute Kidney Injury
Xiaoming Zhou
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 9

Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model
Niroz Abu‐Saleh, Elena Ovcharenko, Hoda Awad, et al.
Life Sciences (2012) Vol. 91, Iss. 13-14, pp. 669-675
Open Access | Times Cited: 31

The Possible Potential Therapeutic Targets for Drug Induced Gingival Overgrowth
Tamilselvan Subramani, Vidhya Rathnavelu, Noorjahan Banu Alitheen
Mediators of Inflammation (2013) Vol. 2013, pp. 1-9
Open Access | Times Cited: 28

The Nax (SCN7A) channel: an atypical regulator of tissue homeostasis and disease
David Dolivo, Adrian E. Rodrigues, Lauren Sun, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 14, pp. 5469-5488
Closed Access | Times Cited: 20

Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects
Jessica Smolander, Bruno Vogt, Marc Maillard, et al.
Clinical Pharmacology & Therapeutics (2009) Vol. 85, Iss. 6, pp. 628-634
Open Access | Times Cited: 32

Acute renal failure and hepatitis following ingestion of carp gallbladder
Shu Wing Kung, Yiu Cheung Chan, ML Tse, et al.
Clinical Toxicology (2008) Vol. 46, Iss. 8, pp. 753-757
Closed Access | Times Cited: 32

Normalizing NADPH Oxidase Contributes to Attenuating Diabetic Nephropathy by the Dual Endothelin Receptor Antagonist CPU0213 in Rats
Ming Xu, De‐Zai Dai, Yin Dai
American Journal of Nephrology (2008) Vol. 29, Iss. 3, pp. 252-256
Closed Access | Times Cited: 32

The Role of Mitochondrial and Redox Alterations in the Skeletal Myopathy Associated with Chronic Kidney Disease
Trace Thome, Kyoungrae Kim, Gengfu Dong, et al.
Antioxidants and Redox Signaling (2022)
Open Access | Times Cited: 11

High salt intake and HIV infection on endothelial glycocalyx shedding in salt-sensitive hypertension
Sepiso K. Masenga, Situmbeko Liweleya, Annet Kirabo
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

Delivery of Recombinant Adeno-Associated Virus-Mediated Human Tissue Kallikrein for Therapy of Chronic Renal Failure in Rats
Ling Tu, Xizhen Xu, Huaibing Wan, et al.
Human Gene Therapy (2008) Vol. 19, Iss. 4, pp. 318-330
Open Access | Times Cited: 29

The Pathophysiology of Endothelin in Complications After Solid Organ Transplantation
Amresh Raina, Edward Horn, Raymond L. Benza
Transplantation (2012) Vol. 94, Iss. 9, pp. 885-893
Open Access | Times Cited: 23

Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies
Valeria Rudomanova, Burns C. Blaxall
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2017) Vol. 1863, Iss. 8, pp. 1883-1892
Open Access | Times Cited: 20

Acute Decompensated Heart Failure and the Kidney: Physiological, Histological and Transcriptomic Responses to Development and Recovery
Miriam T. Rademaker, Anna P. Pilbrow, Leigh J. Ellmers, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 18
Open Access | Times Cited: 15

Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Cecil S. Thompson
Current Pharmaceutical Design (2008) Vol. 14, Iss. 4, pp. 309-324
Closed Access | Times Cited: 25

Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
De‐Zai Dai
Vascular Health and Risk Management (2010), pp. 787-787
Open Access | Times Cited: 22

Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis
Aristotelis Tsiakalos, Gregorios Hatzis, Ioannis Moyssakis, et al.
Hepatobiliary & pancreatic diseases international (2011) Vol. 10, Iss. 4, pp. 393-398
Closed Access | Times Cited: 19

Cardiorenal Syndrome
Andrew A. House
Clinical Journal of the American Society of Nephrology (2013) Vol. 8, Iss. 10, pp. 1808-1815
Open Access | Times Cited: 19

Inhibition of ENaC by Endothelin-1
Andrey Sorokin, Alexander Staruschenko
Vitamins and hormones (2015), pp. 155-187
Open Access | Times Cited: 16

Established and Emerging Strategies in the Treatment of Chronic Kidney Disease
Julio E. Pena-Polanco, Linda F. Fried
Seminars in Nephrology (2016) Vol. 36, Iss. 4, pp. 331-342
Closed Access | Times Cited: 16

Heparanase in Kidney Disease
Johan van der Vlag, Baranca Buijsers
Advances in experimental medicine and biology (2020), pp. 647-667
Closed Access | Times Cited: 15

Scroll to top